Cell therapy strategies for COVID-19: Current approaches and potential applications.
Document Type
Article
Publication Date
8-11-2021
Publication Title
Science Advances
Abstract
Coronavirus disease 2019 (COVID-19) continues to burden society worldwide. Despite most patients having a mild course, severe presentations have limited treatment options. COVID-19 manifestations extend beyond the lungs and may affect the cardiovascular, nervous, and other organ systems. Current treatments are nonspecific and do not address potential long-term consequences such as pulmonary fibrosis, demyelination, and ischemic organ damage. Cell therapies offer great potential in treating severe COVID-19 presentations due to their customizability and regenerative function. This review summarizes COVID-19 pathogenesis, respective areas where cell therapies have potential, and the ongoing 89 cell therapy trials in COVID-19 as of 1 January 2021.
Volume
7
Issue
33
First Page
eabg5995
Last Page
eabg5995
Recommended Citation
Zaki MM, Lesha E, Said K, Kiaee K, Robinson-McCarthy L, George H, Hanna A, Appleton E, Liu S, Ng AHM, Khoshakhlagh P, Church GM. Cell therapy strategies for COVID-19: Current approaches and potential applications. Sci Adv. 2021 Aug 11;7(33):eabg5995. doi: 10.1126/sciadv.abg5995. PMID: 34380619; PMCID: PMC8357240.
DOI
10.1126/sciadv.abg5995
ISSN
2375-2548
PubMed ID
34380619